Novartis scores 1 point higher than Roche Holding on SINK's sustainability index.
Novartis is more sustainable according to SINK's open sustainability index, scoring 50/100 vs Roche Holding's 49/100 — a difference of 1 points.
Novartis scores 50/100 on the SINK sustainability index (Making progress). Novartis has built credible climate infrastructure with SBTi-validated targets and absolute emission reductions across all scopes. However, it relies on carbon credits to claim 2025 neutrality, retains fossil fuel heating, and faces NGO criticism for trade association misalignment on climate policy. Nature strategy remains nascent.
Roche Holding scores 49/100 on the SINK sustainability index (Making progress). Roche has delivered measurable absolute emissions reductions across Scopes 1, 2, and 3, achieved 100% sustainable electricity, and won SBTi validation for net-zero targets. But nature/biodiversity assessment is absent, water targets are intensity-only, and trade association misalignment on climate remains unaddressed.
Both companies are rated on the same 10-question SINK rubric: Scope 1/2/3 carbon footprint, energy source, nature and biodiversity, resource use, water, emissions trajectory, science-based targets, transparency, and controversies. Scores are 0–100, based on public data, and fully reproducible.
See the full leaderboard — 500+ companies ranked.
View full leaderboard →